UNDERWRITING AGREEMENT

Exhibit (e)(4)

THIS AGREEMENT, made as of September,1, 2020, is entered into by and between InvestEd Portfolios (hereinafter the “Trust”), a Delaware statutory trust, on behalf of each series of the Trust listed on the attached Appendix A (each a “Fund” and collectively, the “Funds”) and Ivy Distributors, Inc. (hereinafter “IDI”), a Florida corporation.

REPRESENTATIONS

A. The Trust represents that

1) it is a registered open-end management investment company, and

2) the shares of each of its classes of shares and of each sub-class thereof (“Class”), if any, are, as of the date of the effectiveness of this Agreement as to each such Fund or Class, registered with the Securities and Exchange Commission (“SEC”) and qualified or otherwise authorized for sale in all states of the United States as may be agreed upon. (As to any Fund or Class not registered with the SEC and qualified or otherwise authorized for sale in all states of the United States as may be agreed upon, this Agreement shall become effective as to such Fund or Class upon such registration and qualification or authorization.)

B. IDI represents that

1) it is a broker-dealer registered with the SEC and is duly qualified to offer shares of the Trust in all states in which the shares are currently qualified or otherwise authorized for offer for sale;

2) it is a member of the Financial Industry Regulatory Authority (“FINRA”);

3) it does not engage in the retail sale of Trust shares, but rather maintains agreements with other registered broker-dealers, authorizing such broker-dealers to offer Trust shares to the public;

4) it maintains and enforces procedures reasonably designed to achieve compliance with applicable securities laws, rules and regulations including the Rules of FINRA, including those related to the review and approval of advertising and sales literature used in solicitation of orders to buy Trust shares, and it files, when applicable, such advertising and sales literature with FINRA.

II.

APPOINTMENT OF UNDERWRITER and OBLIGATIONS

The Trust hereby, as applicable, appoints IDI or continues the appointment of IDI, and IDI, as applicable, agrees to act or continues to act, as the Trust’s principal underwriter under the terms and provisions of this Agreement.

Trust agrees

1) to use its best efforts to register from time to time under the Securities Act of 1933 (the “Securities Act”) adequate amounts of its shares for sale to the public through broker-dealers with which IDI contracts and to qualify or to permit IDI to qualify such shares for offering to the public in such states as may from time to time be agreed upon;

2) to immediately advise IDI (i) when any post-effective amendment to its registration statement or any further amendment or supplement thereto or any further registration statement or amendment or supplement thereto becomes effective, (ii) of any request by the SEC for amendments to the registration statement(s) or any then effective prospectus or for additional information, (iii) of the issuance by the SEC of any stop-order suspending the effectiveness of the registration statement or the initiation of any proceedings for that purpose, and (iv) of the happening of any event which makes untrue any material statement made in the registration statement or any then effective prospectus or which, in the opinion of counsel for the Trust, requires the making of a change in the registration statement or any then effective prospectus in order to make the statements therein not misleading; in case of the happening at any time of any event which materially affects the Trust or its securities and which should be set forth in a supplement to or an amendment of any then effective prospectus in order to make the statements therein not misleading, to prepare and furnish to IDI such amendment or amendments to that prospectus as will correct the prospectus so that as corrected it will not contain, or such supplement or supplements to that prospectus which when read in conjunction with that prospectus will make the combined information not contain any untrue statement of a material fact or any omission to state any material fact necessary in order to make the statements in that prospectus not misleading; if any time the SEC shall issue any stop-order suspending the effectiveness of the registration statement, to make every reasonable effort to obtain the prompt lifting of such order; and, before filing any amendment to the registration statement or to any then effective prospectus, to xxxxxxx XXX with a copy of the proposed amendment;

3) to advise IDI of the net asset value of the shares of each of its Funds and Classes, as applicable, as often as computed and to furnish to IDI as soon as practical such information as may be reasonably requested by IDI in order that it may know all of the facts necessary to provide for the sale of shares of the Trust;

4) to pay or cause to be paid all expenses incident to the issuance, transfer, registration and delivery of its shares, all taxes in connection therewith, costs and expenses incident to preparing and filing any registration statements and prospectuses and any amendments or supplements to a registration statement or a prospectus, statutory fees incidental to the registration of additional shares with the SEC, statutory fees and expenses incurred in connection with any Blue Sky law qualifications undertaken by or at the request of IDI, and the fees and expenses of the Trust’s counsel, accountants or any other experts used in connection with the foregoing; and

5) not without the consent of IDI to offer any of its shares for sale directly or to any persons or corporations other than through IDI, except only

a) the reinvestment of dividends and/or distributions or their declaration in shares of the Trust, in optional form or otherwise;

b) the issuance of additional shares to stock splits or stock dividends;

c) sale of shares to another investment or securities holding company in the process of purchasing all or a portion of its assets;

d) in connection with an exchange of shares of the Trust for shares in another investment or securities holding company;

e) the sale of shares to registered unit investment trusts; or

f) in connection with the exchange of one Fund’s shares for shares of another Fund of the Trust.

IDI agrees

1) to offer Trust shares in such states as may be agreed upon through broker-dealers which are members of FINRA on such terms as are not inconsistent with this Agreement;

2) in offering shares through other broker-dealers to comply with the provisions of the Declaration of Trust and Bylaws of the Trust and with the provisions stated in its applicable then current prospectus(es);

3) timely to inform the Trust of any action or proceeding to terminate, revoke or suspend IDI’s registration as a broker-dealer with the SEC, membership in FINRA, or authority with any state securities commission to offer Trust shares; and

4) to pay the cost of all sales literature, advertising and other materials which it may at its discretion use in connection with the sale of Trust shares, including the cost of reports to the shareholders of the Trust in excess of the cost of reports to existing shareholders and the cost of printing the prospectus(es) furnished to it by the Trust.

III.

TERMS FOR SALE OF SHARES

It is mutually agreed that

1) IDI shall act as principal in all matters relating to promotion and sale of Trust shares, including the preparation and use of all advertising, sales literature and other promotional materials, and shall make and enter into all other arrangements, agreements and contracts as principal on its own account and not as agent for the Trust. Title to shares issued and sold by the Trust through IDI shall pass directly from the Trust to the broker-dealer or

investor; except provided, however, that IDI may, if so agreed by IDI and the Trust, act as agent of the Trust without commission on repurchase of shares of the Trust;

2) certificates for shares shall not be created or delivered by the Trust in any case in which the purchase is pursuant to any provisions of the Trust described in its applicable then current prospectus(es) and SAI under the terms of which certificates are not to be issued to the shareholder. Shares sold through IDI shall be registered in such name or names and amounts as the selling broker-dealer or instructor may request from time to time, and all shares when so paid for and issued shall be fully paid and non-assessable; and

3) the offering price at which shares of the Trust may be sold through IDI shall include such selling commission as may be applicable to that Class and as may be fixed from time to time by IDI but shall not be in excess of the maximum permitted under the rules and regulations of FINRA. IDI shall retain any such sales commission and may re-allow all or any part of the sales commission to selected brokers and dealers who sell shares of the Trust. IDI may designate, reduce or eliminate its selling commissions in certain sales or exchanges to the extent described in the applicable then current prospectus(es) of the Trust and in accordance with Section 22(d) of the Investment Company Act of 1940 and any rules, regulations or orders of the SEC thereunder.

IV.

THE PLAN

A. It is mutually acknowledged that the Trust has adopted a plan pursuant to Rule 12b-1 under the Investment Company Act of 1940, as amended (a “Plan”), which Plan is applicable to certain shares and that the Trust may in the future adopt Plans applicable to certain Funds and Classes, respectively.

B. With respect to any Fund or Class as to which the Trust has adopted a Plan, pursuant to that Plan, each day the Trust shall pay to IDI a distribution fee and/or a service fee at the maximum rates and under the terms and conditions set forth in the applicable Plan, as amended from time to time, or such lesser amount as the Trust and IDI may agree.

C. The Trust shall, after excluding from the redemption proceeds that portion represented by the reinvestment of dividends and distributions and the appreciation of the value of Fund shares being redeemed, promptly pay IDI an amount, if any, equal to the percent of the amount invested as determined by IDI and as is then stated in the Trust’s current prospectus applicable to the shares redeemed (the “contingent deferred sales charge”). For purposes of determining the applicable contingent deferred sales charge, if any: the redemptions shall be deemed in order of investment made when more than one investment has been made; and when the shares being redeemed were acquired by exchange of shares of another Fund or Class of the Trust, or corresponding class of another registered investment company for which IDI or its affiliate serves as principal underwriter, the investment shall be deemed as if it had been made when the Trust’s shares were first purchased, and the applicable contingent deferred sales charges, if any, shall be with respect to the amount originally invested in Trust shares; and provided that any contingent deferred sales charge shall be determined in accordance with and in

the manner set forth in the applicable then current prospectus and any applicable Order or Rule issued by the SEC.

D. It is contemplated that IDI may incur expenses substantially in advance of receiving the distribution fee, if any, that may be applicable to the payment of such commissions and expenses. IDI recognizes that such payments are at its risk and that this Agreement may be terminated or not continued as hereinafter provided without the payment to it of any further distribution fees or service fees whatsoever and without the payment of any penalty. The contingent deferred sales charges, if any, shall, however, be payable to IDI with respect to all subject sales made prior to the termination of this Agreement.

E. IDI shall at least quarterly provide to the Trust’s board of trustees a written report with respect to each Fund or Class, as applicable, of the amounts of the distribution and/or service fees expended and the purposes for which these expenditures were made. IDI shall in addition furnish to the board of trustees of the Trust such information as may be requested or as may be necessary to an informed determination by the trustees of whether or not the trustees should continue the Trust’s Plan(s) and continue this Agreement and to determine whether there is reasonable likelihood that the Plan(s) and this Agreement will benefit the Trust and its shareholders affected by such Plan(s).

ANTI-MONEY LAUNDERING DELEGATION

A. Delegation. Each Fund hereby delegates to IDI, as agent for such Fund, responsibility for the implementation and operation of the policies and procedures in connection with the Fund’s Anti-Money Laundering (“AML”) Program (“AML Program”), as applicable to IDI’s functions as a “Service Provider” under the Program and IDI accepts such delegation. IDI further agrees to cooperate with the Fund’s AML Compliance Officer in the performance of IDI’s responsibilities under the AML Program.

B. The AML Program. IDI hereby represents and warrants that IDI has received a copy of each Fund’s AML Program and undertakes to perform all responsibilities imposed on IDI as a “Service Provider” thereunder. Each Fund hereby agrees to provide to IDI any amendment(s) to the AML Program promptly after adoption of any such amendment(s) by the Fund.

C. Consent to Examination. IDI hereby consents to: (a) provide to federal examination authorities information and records relating to the AML Program maintained by IDI; and (b) the inspection of IDI by federal examination authorities for purposes of the AML Program.

D. Anti-Money Laundering Program. IDI hereby represents and warrants that IDI has implemented and enforces an anti-money laundering program (“AMLP”) that is reasonably designed to comply with laws, regulations and regulatory guidance applicable to the Fund and IDI, and includes, if applicable:

1) know-your-customer policies;

2) due diligence policies for correspondent accounts for foreign financial institutions and for private banking accounts for non-U.S. persons;

3) reasonable internal procedures and controls to detect and report suspicious activities;

4) monitoring accounts and identifying high-risk accounts;

5) a compliance officer or committee with responsibility for the AMLP;

6) employee training, including that: (i) new employees receive AML training upon the commencement of their employment; and (ii) existing employees receive AML training at the time such employees assume duties that bring them into contact with possible money laundering activities;

7) an independent audit function; and

8) recordkeeping requirements.

E. Delivery of Documents. IDI agrees to furnish to each Fund the following documents:

1) a copy of IDI’s AMLP as in effect on the date hereof, and any material amendment thereto promptly after the adoption of any such amendment;

2) a copy of any deficiency letter sent by federal examination authorities concerning IDI’s AMLP; and

3) no less frequently than annually, a report on IDI’s AMLP that includes a certification to the Fund concerning IDI’s implementation of, and ongoing compliance with, its AMLP and a copy of any audit report prepared with respect to IDI’s AMLP.

F. Reports. IDI will provide periodic reports concerning IDI’s compliance with IDI’s AMLP and/or each Fund’s AML Program at such times as may be reasonably requested by the Trust’s Board of Trustees or the Anti-Money Laundering Compliance Officer.

VI.

INDEMNIFICATION

A. The Trust agrees with IDI for the benefit of IDI and each person, if any, who controls IDI within the meaning of Section 15 of the Securities Act and each and all and any of them, to indemnify and hold harmless IDI and any such controlling person from and against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Securities Act, under any other statute, at common law or otherwise, and to reimburse the underwriter and such controlling persons, if any, for any legal or other

expenses (including the cost of any investigation and preparation) reasonably incurred by them or any of them in connection with any litigation whether or not resulting in any liability, insofar as such losses, claims, damages, liabilities or litigation arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in any registration statement or any prospectus or any amendment thereof or supplement thereto or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that this indemnity agreement shall not apply to amounts paid in settlement of any such litigation if such settlement is effected without the consent of the Trust or to any such losses, claims, damages, liabilities or litigation arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in any registration statement or prospectus or any amendment thereof or supplement thereto, or arising out of or based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, which statement or omission was made in reliance upon information furnished in writing to the Trust by IDI for inclusion in any registration statement or any prospectus or any amendment thereof or supplement thereto. IDI and each such controlling person shall promptly, after the complaint shall have been served upon IDI or such controlling person in any litigation against IDI or such controlling person in respect of which indemnity may be sought from the Trust on account of its agreement contained in this paragraph, notify the Trust in writing of the commencement thereof. The omission of IDI or such controlling person so to notify the Trust of any such litigation shall relieve the Trust from any liability which it may have to IDI or such controlling person on account of the indemnity agreement contained in this paragraph but shall not relieve the Trust from any liability which it may have to IDI or controlling person otherwise than on account of the indemnity agreement contained in this paragraph. In case any such litigation shall be brought against IDI or any such controlling person and the underwriter or such controlling person shall notify the Trust of the commencement thereof, the Trust shall be entitled to participate in (and, to the extent that it shall wish, to direct) the defense thereof at its own expense but such defense shall be conducted by counsel of good standing and satisfactory to IDI or such controlling person or persons, defendant or defendants in the litigation. The indemnity agreement of the Trust contained in this paragraph shall remain operative and in full force and effect regardless of any investigation made by or on behalf of IDI or any such controlling person and shall survive any delivery of shares of the Trust. The Trust agrees to notify IDI promptly of the commencement of any litigation or proceeding against it or any of its officers or trustees of which it may be advised in connection with the issue and sale of its shares.

B. Anything herein to the contrary notwithstanding, the agreement in Section A of this article, insofar as it constitutes a basis for reimbursement by the Trust for liabilities (other than payment by the Trust of expenses incurred or paid in the successful defense of any action, suit or proceeding) arising under the Securities Act, shall not extend to the extent of any interest therein of any person who is an underwriter or a partner or controlling person of an underwriter within the meaning of Section 15 of the Securities Act or who, at the date of this Agreement, is a trustee of the Trust, except to the extent that an interest of such character shall have been determined by a court of appropriate jurisdiction the question of whether or not such interest is against public policy as expressed in the Securities Act.

C. IDI agrees to indemnify and hold harmless the Trust and its trustees and such officers as shall have signed any registration statement from and against any and all losses, claims, damages or liabilities, joint or several, to which the Trust or such trustees or officers may become subject under the Securities Act, under any other statute, at common law or otherwise, and will reimburse the Trust or such trustees or officers for any legal or other expenses (including the cost of any investigation and preparation) reasonably incurred by it or them or any of them in connection with any litigation, whether or not resulting in any liability insofar as such losses, claims, damages, liabilities or litigation arise out of, or are based upon, any untrue statement or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, which statement or omission was made in reliance upon information furnished in writing to the Trust by IDI for inclusion in any registration statement or any prospectus, or any amendment thereof or supplement thereto, or which statement was made in, or the alleged omission was from, any advertising or sales literature (including any reports to shareholders used as such) which relate to the Trust.

IDI shall not be liable for amounts paid in settlement of any such litigation if such settlement was effected without its consent. The Trust and its trustees and such officers, defendant or defendants, in any such litigation shall, promptly after the complaint shall have been served upon the Trust or any such trustee or officer in any litigation against the Trust or any such trustee or officer in respect of which indemnity may be sought from IDI on account of its agreement contained in this paragraph, notify IDI in writing of the commencement thereof. The omission of the Trust or such trustee or officer so to notify the underwriter of any such litigation shall relieve IDI from any liability which it may have to the Trust or such trustee or officer on account of the indemnity agreement contained in this paragraph, but shall not relieve IDI from any liability which it may have to the Trust or such trustee or officer otherwise than on account of the indemnity agreement contained in this paragraph. In case any such litigation shall be brought against the Trust or any such officer or trustee and notice of the commencement thereof shall have been so given to IDI, IDI shall be entitled to participate in (and, to the extent that it shall wish, to direct) the defense thereof at its own expense, but such defense shall be conducted by counsel of good standing and satisfactory to the Trust. The indemnity agreement of IDI contained in this paragraph shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Trust and shall survive any delivery of shares of the Trust. IDI agrees to notify the Trust promptly of the commencement of any litigation or proceeding against it or any of its officers or trustees or against any such controlling person of which it may be advised, in connection with the issue and sale of the Trust’s shares.

D. Notwithstanding any provision contained in this Agreement, no party hereto and no person or persons in control of any party hereto shall be protected against any liability to the Trust or its security holders to which they would otherwise be subject by reason of willful misfeasance, bad faith, or gross negligence in the performance of their duties or by reason of their reckless disregard of their obligations and duties under this Agreement.

VII.

OTHER TERMS

A. This Agreement shall not be deemed to limit IDI from acting as underwriter, broker and/or dealer for any other mutual fund, from engaging in any other aspects of the

securities business, whether or not such may be deemed in competition with the sale of shares of the Trust, and to carry on any other lawful business whatsoever.

B. Except as expressly provided in Article VI and hereinabove, the agreements herein set forth have been made and are made solely for the benefit of the Trust and IDI, and the persons expressly provided for in Article VI, their respective heirs and successors, personal representatives and assigns, and except as so provided, nothing expressed or mentioned herein is intended or shall be construed to give any person, firm or corporation other than the Trust, IDI and the persons expressly provided for in Article VI any legal or equitable right, remedy or claim under or in respect of this Agreement or any representation, warranty or agreement herein contained. Except as so provided, the term “heirs, successors, personal representatives and assigns” shall not include any purchaser of shares merely because of such purchase.

C. This Agreement shall continue in effect, unless terminated as hereinafter provided, for a period of one (1) year and thereafter only if such continuance is specifically approved at least annually by the Board of Trustees, including the vote of a majority of the trustees who are not parties to the Agreement or “interested persons” (as defined in the Investment Company Act of 1940) or any such party and who have no direct or indirect financial interest in the operation of any Plan or any agreement relating to that Plan (hereafter the “Plan trustees”), cast in person at a meeting called for the purpose of voting on such approval. This Agreement may be terminated by IDI at any time without penalty upon giving the Trust sixty (60) days’ written notice (which notice may be waived by the Trust) and may be terminated by the Trust at any time without penalty upon giving IDI sixty (60) days’ written notice (which notice may be waived by IDI), provided that such termination by the Trust shall be directed or approved by the vote of a majority of the Plan trustees, or by the vote of a majority (as defined in the Investment Company Act of 1940) of the outstanding voting securities of a Fund with respect to that Fund. This Agreement shall automatically terminate in the event of its assignment, the term “assignment” for this purpose having the meaning defined in Section 2(a)(4) of the Investment Company Act of 1940 and applicable Rules thereunder.

D. This Agreement shall be governed and construed in accordance with the laws of Kansas.

Exhibit (e)(4)

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective duly authorized officers and their corporate seals to be affixed as of the day and year first above written.


INVESTED PORTFOLIOS:

By:		/s/ Xxxx X. Xxxxx
		Xxxx X. Xxxxx, Chief Legal Officer


ATTEST:

By:		/s/ Xxxxxxxx X. Xxxxxx
		Xxxxxxxx X. Xxxxxx, Secretary


IVY DISTRIBUTORS, INC.

By:		/s/ Xxx X. Xxxxxxx
		Xxx X. Xxxxxxx, President


ATTEST:

By:		/s/ Xxxxxxx Xxxxx
		Xxxxxxx Xxxxx, Secretary

Exhibit (e)(4)

APPENDIX A

INVESTED PORTFOLIOS FUND NAMES

InvestEd 90 Portfolio

InvestEd 80 Portfolio

InvestEd 70 Portfolio

InvestEd 60 Portfolio

InvestEd 50 Portfolio

InvestEd 40 Portfolio

InvestEd 30 Portfolio

InvestEd 20 Portfolio

InvestEd 10 Portfolio

InvestEd 0 Portfolio

Document Metadata

Table of Contents

UNDERWRITING AGREEMENT

Document Metadata